Varonis Systems, Inc. (LON:0VOU)

Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	199.23	185.59	230.74	367.8	805.76	234.09
Short-Term Investments	608.22	385.1	304.01	365.09	2.18	64.53
Cash & Short-Term Investments	807.45	570.69	534.75	732.89	807.94	298.62
Cash Growth	28.72%	6.72%	-27.04%	-9.29%	170.56%	147.26%
Accounts Receivable	149.7	192.83	169.12	135.98	117.18	94.23
Other Receivables	-	43.79	15.41	7.18	3.33	1.59
Receivables	149.7	236.62	184.52	143.16	120.51	95.82
Prepaid Expenses	96.74	28.54	22.78	10.22	6.75	7.94
Other Current Assets	14.47	42.23	25.1	19.39	24.01	17.48
Total Current Assets	1,068	878.07	767.16	905.66	959.21	419.85
Property, Plant & Equipment	74.83	76.39	85.8	95.82	102.05	85.09
Long-Term Investments	364.2	658.9	211.06	-	-	-
Goodwill	39.75	23.14	23.14	23.14	23.14	23.14
Other Intangible Assets	5.84	-	1.26	2.79	4.31	5.85
Other Long-Term Assets	62.02	27.78	15.49	16.34	19.84	21.57
Total Assets	1,615	1,664	1,104	1,044	1,109	555.48
Accounts Payable	7.12	4.31	0.67	2.96	5.32	0.85
Accrued Expenses	173.23	151.18	115	97.91	93.37	83.2
Current Portion of Long-Term Debt	251.15	250.53	-	-	-	-
Current Portion of Leases	11.4	10.85	10.05	9.87	8.79	-
Current Unearned Revenue	322.79	290.11	181.05	110.55	104.22	98.59
Other Current Liabilities	5.72	2.9	0.01	7.45	0.06	-
Total Current Liabilities	771.4	709.89	306.78	228.74	211.77	182.64
Long-Term Debt	451.25	450.24	250.48	248.96	225.33	218.46
Long-Term Leases	39.87	42.79	51.31	57.63	68.69	54.54
Long-Term Unearned Revenue	0.11	2.21	0.89	1.5	2.57	2.78
Other Long-Term Liabilities	10.9	0.54	2.06	2.41	0.71	0.27
Total Liabilities	1,274	1,209	614.26	541.61	511.94	461.41
Common Stock	0.11	0.11	0.11	0.11	0.11	0.1
Additional Paid-In Capital	1,139	1,193	1,143	1,055	1,018	395.35
Retained Earnings	-811.76	-740.16	-644.39	-543.47	-427.6	-310.74
Comprehensive Income & Other	14.5	2.68	-8.65	-9.56	6.08	9.37
Shareholders' Equity	341.5	455.66	489.65	502.13	596.59	94.07
Total Liabilities & Equity	1,615	1,664	1,104	1,044	1,109	555.48
Total Debt	753.66	754.41	311.84	316.46	302.82	273
Net Cash (Debt)	417.99	475.18	433.98	416.43	505.12	25.62
Net Cash Growth	-13.56%	9.49%	4.21%	-17.56%	1871.65%	-59.80%
Net Cash Per Share	3.72	4.26	3.98	3.81	4.80	0.27
Filing Date Shares Outstanding	112.05	112.55	109.1	107.62	107.51	95.5
Total Common Shares Outstanding	112.05	112.55	109.1	107.67	107.51	95.46
Working Capital	296.97	168.19	460.38	676.91	747.44	237.21
Book Value Per Share	3.05	4.05	4.49	4.66	5.55	0.99
Tangible Book Value	295.91	432.52	465.25	476.2	569.15	65.09
Tangible Book Value Per Share	2.64	3.84	4.26	4.42	5.29	0.68
Machinery	-	37.01	33.61	34.72	29.98	24.58
Leasehold Improvements	-	45.06	45.88	45.52	42.42	37.39

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.